Receptor patterns define key organizational principles in the brain, scientists have discovered.
FDA accepts UroGen’s UGN-102 NDA for bladder cancer treatment
Bladder cancer is the second most common urologic cancer in US men. Credit: SaiArLawKa2/Shutterstock. UroGen Pharma has received the new drug application (NDA) acceptance from